programme
13TH June 2014
15:00 - 15:45
15:45 – 15:55
15:55 – 16:00 16:00 – 16:45 16:45 – 17:00 17:00 – 17:15 17:15 – 17:30 17:30 – 17:45 18:30 20:00 |
Registration
Welcome
address and meeting rationale
Giacinto Bagetta (Cosenza) Presentation of the Invited Speaker Diana Amantea (Cosenza) Opening lecture “Gliotransmission in Health and Disease” Paola Bezzi (Department of Fundamental Neurosciences, University of Lausanne, Switzerland) Coffee break ORAL COMMUNICATIONS Chairpersons: Francesca Fallarino (Perugia), Luigi A. Morrone (Cosenza) The dopaminergic phenotype of frontal cortex astrocytes Petrelli F., Pucci L., Calì C., Knott G., Magrassi L., Asensio C., Edwards R., Bezzi P. Astrocytic mitochondrial impairments in animal model of 22q11 deletion syndrome Pucci L., Petrelli F., Lopatar J., Magrassi L., Henry H., Gogos J.A., Magistretti P., Lengacher S., Rossi D., Bezzi P. Repurposing antithrombin as a new strategy for stroke intervention Cuomo O., Pignataro G., Gala R., Scorziello A., Gravino E., Piazza O., Tufano R., Di Renzo G., Annunziato L. Guided tour at “Museo dei Brettii e degli Enotri” Dinner at “Enoteca Regionale della Provincia di Cosenza” |
14TH june 2014
8:45 – 9:15
9:15 – 9:30 9:30 – 9:45 9:45 – 10:00 10:00 – 10:15 10:15 – 10:30 10:30 – 10:45 10:45 – 11:00 11:00 – 11:15 11:15 – 11:45 11:45 – 12:00 12:00 – 12:15 12:15 – 12:30 12:30 – 12:45 12:45 – 13:00 13:00 – 13:15 13:15 – 13:30 13:30 – 13:45 14:00 |
Keynote lecturer: Eugenio Donato Di Paola (MD,
Professor of Pharmacology, School of Medicine, University
“Magna Graecia” of Catanzaro and Trial Office coordinator, Azienda Ospedaliera San Camillo-Forlanini, Roma)
“Ethical and regulatory aspects of new drugs R&D" ORAL COMMUNICATIONS Chairpersons: Laura Berliocchi (Catanzaro), Eugenio Donato Di Paola (Catanzaro) Niacin-activated G protein estrogen receptor (GPER) signalling triggers protumoral or anti-inflammatory effects in distinct experimental models Santolla M.F., De Francesco E.M., Lappano R., Rosano C., Abonante S., Maggiolini M. Autophagy modulation in retina neurodegenerative diseases: new possibilities for drug repositioning Russo R., Adornetto A., Cavaliere F., Varano G.P., Morrone L.A., Corasaniti M.T., Bagetta G. PEA administration ameliorates the clinical manifestation and progression of experimental autoimmune encephalomyelitis in rodents Bruschetta G., Impellizzeri D., Di Paola R., Cordaro M., Siracusa R., Ahmad A., Crupi R., Paterniti I., Campolo M., Esposito E., Cuzzocrea S. Mitotane activates GPER-dependent pathways leading to apoptosis of human adrenocortical carcinoma H295R cell line Chimento A., Sirianni R., Casaburi I., Paola A., Domanico F., De Luca A., Campana C., Martire E., Pezzi V. Sodium valproate use associated with tremor in epileptic patient with Down’s syndrome Siniscalchi A., Cutrupi S., Loizzo S. Current opportunities for drug repurposing in pain management: is there a role for autophagy modulation? Berliocchi L., Maiarù M., Russo R., Scuteri D., Varano G.P., Chiappini C., Tassorelli C., Bagetta G., Corasaniti M.T. Stealth liposomes encapsulating zoledronic acid: A new opportunity to treat neuropathic pain Guida F., Caraglia M., Luongo L., Salzano G., Zappavigna S., Marra M., Lusa S., Giordano C., De Novellis V., Rossi F., Abbruzzese Saccardi A., De Rosa G., Maione S. Coffee break Keynote lecturer: Francesca Fallarino (Professor of Pharmacology, Department of Experimental Medicine, University of Perugia) “Aryl hydrocarbon Receptor: a novel drug-repurposing target to control inflammatory responses” Fallarino F., Gargaro M., Mondanelli G., Bessede A., Matino D., Pallotta M.T., Vacca C., Romani R., Funakoshi H., Grohmann U., Puccetti P. ORAL COMMUNICATIONS Chairpersons: Franca Orsini (Milano), Rossella Russo (Cosenza) Repurposing drugs for ischemic brain injury Buonvicino D., Muzzi M., Gerace E., Coppi E., Pugliese A.M., Chiarugi A. Complement C1-inhibitor in ischemic brain injury Orsini F., De Simoni M.G. Combination of hypothermia with memantine or topiramate: neuroprotection studies in in vitro and in vivo models of neonatal hypoxic-ischemic brain injury Gerace E., Landucci E., Filippi L., Scartabelli T., Guerrini R. and Pellegrini-Giampietro D.E. Targeted acetyation of NF-kappaB and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window Lanzillotta A., Pignataro G., Branca C., Cuomo O., Sarnico I., Benarese M., Annunziato L., Spano P.F., Pizzi M. Preclinical evidence for repurposing an RXR agonist for stroke therapy Certo M., Amantea D., Endo Y., Bagetta G. On drug repurposing in autoimmune diabetes: proteasome inhibitors as new immunotherapeutic agents Orabona C., Albini E., Volpi C., Belladonna M.L., Fallarino F., Pallotta M.T., Vacca C., Bianchi R., Grohmann U., Puccetti P. Polarization of the immune response by a macrolide antibiotic for clinical translation in stroke Amantea D., Certo M., Petrelli F., Corasaniti M.T., Bagetta G. Concluding remarks Lunch |
|
Web Editor: Dott. Michelangelo Certo, PhD
([email protected]) |